Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis
Open Access
- 20 November 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
Abstract
Objective: To assess treatment-related spatio-temporal dynamics of active MRI lesions in relapsing-remitting multiple sclerosis (RRMS) patients. Methods: We performed a post-hoc analysis of MRI data acquired at weeks 4, 8, 12, and 16, in RRMS patients from the multicenter randomized IMPROVE study, which compares patients treated with 44 mcg subcutaneous interferon β-1a three times weekly (n = 120) versus placebo (n = 60). We created lesion probability maps (LPMs) of the cumulative combined unique active (CUA) lesions in each patient group at each time point. Group differences were tested in terms of lesion spatial distribution and frequency of occurrence. Results: Spatial distribution of CUA lesions throughout the study was less widespread in the treated than placebo group, with a 50% lower lesion accrual (24 vs. 48 cm3/month). Similar results were obtained with the WM tract analysis, with a reduction ranging from −47 to −66% in the treated group (p < 0.001). On voxel-wise analysis, CUA lesion frequency was lower in the treated group than the placebo group at week 4 (p = 0.07, corrected), becoming particularly pronounced (p ≤ 0.03, corrected) from week 8 onwards in large clusters of WM tracts, with peaks along fronto-parietal parts of the corticospinal tract, thalamic radiation, and superior longitudinal fascicle. Conclusion: LPM showed, in the short term, a treatment-related reduction of MRI lesion activity in RRMS patients in specific, clinically relevant brain locations. Such a quantitative approach might be a promising additional endpoint in future MS studies alongside the number and volume of WM lesions. Clinical Trial Registration: ClinicalTrials.gov identifier NCT00441103.Funding Information
- Merck KGaA
This publication has 25 references indexed in Scilit:
- Distinction of seropositive NMO spectrum disorder and MS brain lesion distributionNeurology, 2013
- Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosisNeurology, 2013
- Relevance of Brain Lesion Location to Cognition in Relapsing Multiple SclerosisPLOS ONE, 2012
- Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple SclerosisPLOS ONE, 2011
- Imaging distribution and frequency of cortical lesions in patients with multiple sclerosisNeurology, 2010
- T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Voxel-Based Assessment of Differences in Damage and Distribution of White Matter Lesions Between Patients With Primary Progressive and Relapsing-Remitting Multiple SclerosisArchives of Neurology, 2008
- Lesion probability maps of white matter hyperintensities in elderly individualsZeitschrift für Neurologie, 2006
- Anatomical Mapping of White Matter Hyperintensities (WMH)Stroke, 2005
- Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesionsAnnals of Neurology, 1997